BIAL - PORTELA & CA. S.A. et al v. Hetero Labs Limited et al
BIAL - PORTELA & CA. S.A., Sunovion Pharmaceuticals Inc. and Bial - Holding, S.A. |
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-V |
1:2020cv00780 |
June 9, 2020 |
US District Court for the District of Delaware |
Christopher J Burke |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on July 30, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 15 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,675,287; 10,695,354; 10,702,536. (Attachments: #1 Consent Judgment)(nmf) |
Filing 14 CONSENT JUDGMENT Signed by Judge Colm F. Connolly on 7/29/2020. (nmf) |
Filing 13 PROPOSED CONSENT JUDGMENT by BIAL - PORTELA & CA. S.A., Bial - Holding, S.A., Bial - Portela & CA S.A.. (Balick, Steven) |
Filing 12 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes relating to discovery or the protective order. Joinder of Parties due by 12/18/2020. Amended Pleadings due by 12/18/2020. Fact Discovery completed by 1/29/2021. Expert Discovery due by 7/16/2021. Joint Claim Construction Brief due by 1/5/2021. A Markman Hearing is set for 2/16/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 8/24/2021. A Final Pretrial Conference is set for 9/14/2021 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/27/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 7/20/2020. Associated Cases: 1:18-cv-00279-CFC-CJB et al.(nmf) |
SO ORDERED, re (136 in 1:18-cv-00312-CFC-CJB, 133 in 1:18-cv-00336-CFC-CJB, 136 in 1:18-cv-00341-CFC-CJB, 12 in 1:20-cv-00781-CFC, 148 in 1:18-cv-00382-CFC-CJB, 146 in 1:18-cv-00279-CFC-CJB, 132 in 1:18-cv-00342-CFC-CJB, 9 in 1:20-cv-00784-CFC, 11 in 1:20-cv-00780-CFC, 134 in 1:18-cv-00304-CFC-CJB, 9 in 1:20-cv-00785-CFC, 9 in 1:20-cv-00782-CFC, 9 in 1:20-cv-00783-CFC, 9 in 1:20-cv-00786-CFC) [SEALED] STIPULATION Regarding Case Management of Original and Newly Filed Actions. Signed by Judge Colm F. Connolly on 7/20/2020. Associated Cases: 1:18-cv-00279-CFC-CJB et al.(nmf) |
Filing 11 [SEALED] STIPULATION Regarding Case Management of Original and Newly Filed Actions, by Bial - Holding, S.A., Bial - Portela & CA S.A., BIAL - PORTELA & CA. S.A.. (Attachments: #1 Exhibit 1)(Balick, Steven) |
Filing 10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,695,354 ;10,702,536 . (Balick, Steven) |
Filing 9 Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 5/6/2025.Thirty Month Stay Deadline: 5/8/2021. (Balick, Steven) |
Filing 8 AMENDED COMPLAINT against All Defendants - filed by BIAL - PORTELA & CA. S.A., Bial - Holding, S.A.. (Attachments: #1 Exhibit A-C)(Balick, Steven) |
Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent none for Hetero Labs Limited, Hetero Labs Limited Unit-V; Corporate Parent Hetero Drugs Limited, Corporate Parent Hetero Labs Limited for Hetero USA Inc. filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc.. (Moore, David) |
Filing 6 ANSWER to #1 Complaint, by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc..(Moore, David) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:20-cv-00780-CFC through 1:20-cv-00786-CFC (rjb) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sumitomo Dainippon Pharma Co. Ltd. for Sunovion Pharmaceuticals Inc.; Corporate Parent Bial - Holding, S.A. for BIAL - PORTELA & CA. S.A.; Corporate Parent No parent corporations for Bial - Holding, S.A. filed by BIAL - PORTELA & CA. S.A., Bial - Holding, S.A., Sunovion Pharmaceuticals Inc.. (Mayo, Andrew) |
No Summons Issued. (nmg) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,675,287. (nmg) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 5/6/2025.Thirty Month Stay Deadline: 5/8/2021. (nmg) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2983434.) - filed by BIAL - PORTELA & CA. S.A., Sunovion Pharmaceuticals Inc., Bial - Holding, S.A. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.